-Bloomberg
BMO Capital Maintains Underperform on World Acceptance, Lowers Price Target to $32
BMO Capital analyst James Fotheringham maintains World Acceptance (NASDAQ:WRLD) with a Underperform and lowers the price target from $46 to $32.
Related Posts
SVB Leerink Maintains Outperform on HCA Healthcare, Raises Price Target to $259
SVB Leerink analyst Whit Mayo maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises the price target from $240 to $259.
Jim Cramer Says Don’t Trust Any Rally In September Unless These 2 Things Happen
CNBC's Jim Cramer cautioned against taking any September bounce at the face value as he pointed to two risks that can derail the market.
Argo Blockchain Divests Mining Facility Helios For $65M As It Battles Bankruptcy Concerns
Argo Blockchain Plc (NASDAQ:ARBK) subsidiary agreed to sell its Helios facility and real property in Dickens County, Texas, and…